ESQ vs GILD · P/E 18, rev $80.3M vs P/E 18, rev $7.80B
Esquire Financial Holdings Inc (ESQ) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Esquire Financial Holdings Inc (ESQ) is a banks - regional company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported ESQ revenue for 2026-06-30 was $80.3M. Net income was $25.2M. ESQ currently screens at market cap $933.8M and trailing P/E 18.2.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
ESQ currently screens at market cap $933.8M and trailing P/E 18.2. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the ESQ and GILD stock pages for the full models.
Not investment advice.